



A 76-year-old man was seen with small bowel and
bilateral lower extremity ischemia at another hospital in
1991. He underwent small-bowel resection and bilateral
lower extremity thrombectomies. An embolectomy of
both the femoral and the popliteal arteries and of the right
posterior tibial artery was performed, but the flow was not
restored to the right foot. The embolectomy specimen
and the thrombus from the mesenteric vessels were
described as a thromboembolizing myxoma. After the
patient was transferred to our facility, further embolecto-
my was performed on the right popliteal, the posterior tib-
ial, and the dorsalis pedis arteries. The posterior tibial and
the dorsalis pedis arteries were occluded at the ankle. Soon
afterward, the abdomen was reexplored for progressive
gangrene of the small bowel, and an additional small-
bowel resection was necessary. The embolic material from
the mesenteric and lower extremity arteries again appeared
to originate from an atrial myxoma. An embolus that orig-
inated from the heart or the aorta proximal to the superi-
or mesenteric artery was suspected; however, a trans-
esophageal echocardiogram did not show cardiac throm-
bus, atrial myxoma, or thoracic aortic disease. It was
postulated that a mxyoma had completely dislodged and
embolized. Because the right lower extremity remained
ischemic, a below-knee amputation became necessary. 
Serial transesophageal echocardiography continued to
show no evidence of cardiac or aortic disease. After
remaining asymptomatic for 2 years, the patient was seen
in May 1993 with an acute onset of left foot pain and
numbness. The patient required aortic and bilateral
iliofemoral thrombectomies to restore perfusion to both
limbs. The embolic material now exhibited chondroma-
tous features. A review of the pathology, performed by the
Armed Forces Institute of Pathology, favored a diagnosis
of chondrosarcoma, although the source was not certain.
The possibility of a primary aortic sarcoma prompted an
arteriogram, which revealed an aortic filling defect in the
area of the bifurcation (Fig 1). No abnormality was seen
in the thoracic aorta (Fig 2). At that time, this was the
only known case of an aortic chondrosarcoma at the
Armed Forces Institute of Pathology. Magnetic resonance
imaging (MRI) showed a questionable defect in the
descending thoracic aorta that was thought to represent a
small mural thrombus or plaque.
In November 1993, the patient subsequently under-
went resection of the infrarenal aortic tumor and the com-
mon iliac arteries and replacement with a bifurcated
Dacron graft. The aortic tumor appeared to originate
from the intima and did not invade the media (Figs 3
through 5). There was no periaortic lymph node involve-
ment. At the time of the exploration, a biopsy specimen
taken from a suspicious liver nodule was found to repre-
sent metastatic chondrosarcoma. A computed tomograph-
ic scan and an MRI showed no change in the filling defect
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that was seen previously in the descending thoracic aorta
(Fig 6). This finding supported the prior conclusion that
this was a plaque or a mural thrombus. Approximately 1
year later, a repeat MRI revealed the progression of the
intraluminal lesion with a reduction of 50% in the thoracic
aortic lumen. It was now more convincing that this lesion
was the proximal source of embolization.
In January 1995, the patient again was seen at our hos-
pital with left lower extremity ischemia that necessitated
thrombectomy. The thrombus that was recovered from the
left limb of the bypass graft exhibited the same features as a
chondromatous tumor. The mass in the thoracic aorta was
resected soon thereafter, at another facility, with the aid of
left atrial to distal descending thoracic aorta cardiofemoral
bypass grafting and cerebrospinal fluid drainage. The
descending thoracic aorta was replaced with a Dacron graft.
The histologic study of the tumor revealed a low-grade
chondrosarcoma with myxoid features that involved the
intimal, medial, and adventitial layers. Embolectomies of
the left common femoral and popliteal arteries were neces-
sary to restore perfusion to the left leg. During the surgery,
the aortic bifurcation graft occluded. Revascularization was
performed with a right axillary bifemoral graft. The pro-
gressive gangrene of the left lower extremity led to a below-
knee amputation. The continued follow-up of the patient
revealed metastatic disease in the left thigh, which was treat-
ed with radiation. He eventually died in July 1997—53⁄4
years after he was initially seen in 1991.
DISCUSSION
Brodowski,1 in 1873, reported the first case of a
primary aortic tumor. Since then, at least 70 prima-
ry aortic malignant tumors have been described.2-12
These tumors can involve both the abdominal and
the thoracic aorta.3,6,8 Men seem to be affected
more commonly than women.7,9 The mean age at
presentation among a group of 11 patients with aor-
tic sarcomas compiled by Burke and Virmani13 was
62.3 years. Aortic tumors may present with emboli
to the bowel or the lower extremities, as in this case.
They also may result in back pain or in aneurysm
formation and subsequent rupture.13 At times, the
tumors may be misinterpreted as pseudoaneurysms
after prosthetic grafting.10 Ingeholm and Engel11
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Fig 1. Abdominal aortogram shows filling defect in area
of bifurcation.
Fig 2. Thoracic aortogram shows no abnormality.
reported a case in an 82-year-old man with dyspha-
gia and esophageal metastases. Aortic tumors also
may be seen with hypertension that results from the
involvement of the renal arteries or the obstruction
of the aortic lumen.9,12,14
The diagnosis of aortic sarcomas is challenging
because these tumors rarely are identified before
surgery. More often, they are discovered at laparoto-
my or are revealed in the pathology report from an
embolectomy, which was thought to be only throm-
bus at the time of the operation.12,13 Other tumors
are diagnosed postmortem.12 However, for any
patient with repeated or unexplained embolic events,
the possibility of tumor embolization should be con-
sidered. An organized approach to determine the
source is essential. After a review of the pathology
report, which may give some clue as to the origin of
the embolus, the heart should be evaluated for atrial
tumors or mural thrombi. An echocardiogram, either
transthoracic or transesophageal, should be obtained.
The next investigational step should be aortic imag-
ing. Noninvasive studies, such as abdominal and chest
computed tomography or MRI, should be ordered
initially. MRI has been postulated to be more helpful
in distinguishing tumor from thrombus.7 If these
studies are nondiagnostic, further information can be
gained from an abdominal aortogram, and a thoracic
aortic evaluation can be added at the same setting if
the abdominal views are unremarkable. 
The cause of aortic tumors has been thought, by
Kattas et al,15 to involve the malignant degeneration of
an intraluminal fibrin-rich platelet thrombus. A second
explanation, offered by Iwasaki et al,16 has described
the malignant transformation of the primitive mes-
enchymal cells. This explanation seems appropriate for
this tumor because the initial thrombus that was recov-
ered from the lower extremity, which was diagnosed
then as atrial myxoma, was remarkable for a more
primitive cell line. Histologically, the myxomatous cells
appear much like undifferentiated mesenchymal cells.
The classification systems for aortic sarcomas
have been designed by Salm17 and Wright et al.18
The former author divides the aortic sarcomas into
3 groups on the basis of the layers of the aortic wall.
These groups are the polypoid and intraluminal, the
intimal, and the adventitial. The polypoid and intra-
luminal tumors are pedunculated and grow within
the lumen. These tumors may embolize and project
into the mesenteric branches. The intimal tumors
narrow the lumen by forming plaques and also can
involve the mesenteric branches.17 The adventitial
tumors are seen late, usually with distant metas-
tases.9 They generally are not occlusive.17 The clas-
sification system that was proposed by Wright et al18
categorizes the tumors on the basis of the site of ori-
gin. This system includes intimal and medial or
adventitial tumors. The intimal tumors are seen with
embolic metastatic events, and the latter group may
only have symptoms of a generalized nature, such as
weight loss or fever.18
Different histologic patterns have been associat-
ed with the aortic tumors and are characterized as
fibrosarcoma, leiomyosarcoma, undifferentiated
tumor, malignant fibrous histiocytoma, and angio-
sarcoma. Angiosarcoma is the most common type.12
Karabinis et al9 also have reported a myxoid chon-
drosarcoma that is like the one in the present case.9
This is the only other case of an aortic chondrosar-
coma that is known to us.
Immunohistochemical markers are useful for the
determination of differentiation and of the cell of
origin. The presence of factor VIII, which is pro-
duced by endothelial cells, suggests an endothelial
origin.19 The absence of this characteristic, however,
does not exclude a tumor of intimal origin. For
example, in one report, the intimal sarcomas were
deficient of factor VIII. Likewise, they were lacking
in desmin, keratin, and S-100 protein, which are
markers that indicate smooth muscle, epithelial, and
neural differentiation. The intimal sarcomas did have
JOURNAL OF VASCULAR SURGERY
Volume 28, Number 5 Clark et al 941
Fig 3. Intraluminal aortic tumor with probe that extends
to left common iliac artery. Fig 4. Adventitial view of aortic tumor.
actin and vimentin overall supporting the presence
of a myofibroblastic tumor.13,20,21 The tumor in our
patient stained positive for vimentin and S-100,
which are both nonspecific markers in this case.
The treatment of aortic sarcomas often is limited
by a delayed diagnosis and by advanced disease.
Palliative resection is performed for the symptomatic
tumors. Resection, chemotherapy, and radiation have
not been shown to increase the survival rates.7,9,12
Doxorubicin has been used alone or in combination
with dacarbazine and vincristine sulfate or with vin-
cristine sulfate and cyclophosphamide.13 The recur-
rent disease in one patient who was at good risk was
treated with doxorubicin and ifosfamide, which was
followed by 6000 rads of radiation.7
Prolonged survival times after the resection of
primary aortic tumors are rare. Iwasaki et al16 report-
ed an average of 8 months of survival time after
resection and vascular reconstruction. Malone et al6
described an average survival time of 11⁄2 years for
patients with vascular sarcomas. In a series of 11 aor-
tic sarcomas reported by Burke and Virmani,13 2
patients were alive and well at 14 years and 5 years.
Another patient with malignant fibrous histiocytoma
was alive at 6 years.4 A final patient with an aortic sar-
coma lived 8 years from the initial diagnosis.5
Although not the longest known survivor, the pre-
sented patient survived 69 months.
JOURNAL OF VASCULAR SURGERY
942 Clark et al November 1998
Fig 5. Histology shows the intimal tumor with no invasion of media.
Fig 6. Magnetic resonance imaging scan shows filling
defect (white arrow) in descending thoracic aorta.
CONCLUSION
Chondrosarcoma of the aorta is an extremely
rare tumor, presenting, in this case, as emboli to the
bowel and to the lower extremities. This disease,
which is often mistaken before surgery, should be
considered to correctly identify and treat these
tumors expediently. Although the survival rates are
generally poor, this patient survived for 69 months.
We thank Ms Audrey Smith for her much appreciated
help in the preparation of the manuscript.
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